linagliptin · Powder

What changed in the last 90 days

Every detected change for linagliptin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Dipeptidyl Peptidase 4 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• alogliptin and pioglitazone· 1 maker
• empagliflozin and linagliptin· 1 maker
• empagliflozin, linagliptin, metformin hydrochloride· 1 maker
• saxagliptin and metformin· 1 maker
• saxagliptin and metformin hydrochloride· 1 maker
• sitagliptin hydrochloride oral· 1 maker
• alogliptin benzoate and pioglitazone hydrochloride· 2 makers
• ertugliflozin and sitagliptin· 2 makers
• linagliptin and metformin hydrochloride· 4 makers
• alogliptin and metformin hydrochloride· 5 makers
• saxagliptin· 6 makers
• alogliptin· 8 makers

Common questions

Is Linagliptin in shortage right now?

No. FDA does not currently list Linagliptin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Linagliptin?

20 companies have marketed Linagliptin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Linagliptin cost?

The typical pharmacy pays about $16.80 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.